hodgkin lymphoma: prognostic markers in the era of novel treatments
Published 1 year ago • 79 plays • Length 1:59Download video MP4
Download video MP3
Similar videos
-
6:16
overview of novel restore and target treatment approach to classical hodgkin lymphoma
-
1:24
novel agents for the treatment of hodgkin lymphoma: brentuximab vedotin and nivolumab
-
2:03
novel therapeutic agents in the treatment of hodgkin and non-hodgkin lymphoma
-
1:34
pet-guided treatment: the new standard of care in hodgkin lymphoma?
-
1:27
diagnosis and risk stratification in hodgkin lymphoma: updates and novel approaches
-
4:58
doctor explains warning symptoms and signs of hodgkin's lymphoma cancer
-
7:15
classic case: hodgkin's lymphoma
-
14:06
hodgkin lymphoma (updated 2023) - crash! medical review series
-
1:27
challenges in understanding the genomic landscape of hodgkin lymphoma
-
2:42
the current role of chemotherapy in the treatment of hodgkin lymphoma & the impact of novel agents
-
1:25
the current approach to managing patients with prefibrotic pmf
-
5:29
developing new prognostic scores in hodgkin lymphoma
-
1:09
novel immunotherapy combinations in hodgkin lymphoma
-
1:36
the changing role of chemotherapy in lymphoma and the value of novel immunotherapies
-
7:52
hodgkin’s lymphoma (hodgkin disease) - quick review - hematology and oncology series
-
2:40
exploring the genomic landscape of hodgkin lymphoma with whole-genome sequencing
-
12:21
non-hodgkin lymphoma - causes, symptoms, diagnosis, treatment, pathology
-
1:15
biomarkers being explored in hodgkin lymphoma: the role of ctdna
-
1:37
the role of ctdna in hodgkin lymphoma
-
2:39
new findings and challenges in the use of immunotherapy in hodgkin lymphoma
-
4:07
hodgkin lymphoma & non-hodgkin lymphoma treatment
-
1:13
treatment combinations in hodgkin lymphoma